Literature DB >> 25118732

Prevalence of extended spectrum beta-lactamase producing uropathogens and their antibiotic resistance profile in patients visiting a tertiary care hospital in central India: Implications on empiric therapy.

Trupti Bajpai1, Maneesha Pandey, Meena Varma, Ganesh S Bhatambare.   

Abstract

CONTEXT: Antimicrobial resistance showed by different uropathogens is one of the barricades that might hinder a successful treatment. Detection of extended spectrum beta-lactamase (ESBL) production among uropathogens is an important marker of endemicity. AIMS: The present prospective study was done to identify the trends of uropathogens, to find the prevalence of ESBL isolates and to study the antibiotic resistance profile of the ESBL and non-ESBL uropathogenic isolates.
MATERIALS AND METHODS: This study was conducted in the Department of Microbiology of a teaching tertiary care hospital from July 2013 to September 2013. All the uropathogenic isolates were identified up to species level by conventional methods. The prevalence of potential ESBL producers was explored. Antibiotic resistance test of the urinary isolates was done by disc-diffusion method and the results were interpreted according to Clinical Laboratory Standards Institute-2013 guidelines.
RESULTS: A total of 670 urine samples from male and female patients visiting the outpatient department (OPD) and inpatient department (IPD) of our hospital were collected. A significantly higher number of IPD and OPD males (55.1% and 55.5%) were found to be culture positive. Escherichia coli (55.3%) was the most frequently isolated uropathogen followed by Klebsiella pneumoniae (23%). However, strains of Escherichia coli (41.6%) were the highest ESBL producing isolates followed by Pseudomonas aeruginosa (36.1%). ESBL producing isolates were found to be multidrug-resistant when compared to non-ESBL producers. However, excessive drug-resistance among non-ESBL producing isolates can't be ignored.
CONCLUSION: Our study confirms a global trend toward increased resistance to beta-lactam antibiotics. We emphasize on the formulation of antibiotic policy for a particular geographical area.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25118732     DOI: 10.4103/0377-4929.138733

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  7 in total

1.  A Randomized Controlled Trial to Study the Rationale of Antibiotic Prophylaxis in Diagnostic Rigid Cystoscopy: A Relook in The Era of Antibiotic Stewardship.

Authors:  Harmandeep Singh Chahal; Shagun Sikka; Simran Kaur; Varun Mittal; Baldev Singh Aulakh; Sandeep Sharma
Journal:  Int J Appl Basic Med Res       Date:  2021-07-19

2.  Extended-spectrum ß-Lactamase-producing Enterobacteriaceae as a Common Cause of Urinary Tract Infections in Sri Lanka.

Authors:  L Gayani Tillekeratne; Dhammika Vidanagama; Rashmi Tippalagama; Rashmi Lewkebandara; Maria Joyce; Bradly P Nicholson; Ajith Nagahawatte; Champica K Bodinayake; Aruna Dharshan De Silva; Christopher W Woods
Journal:  Infect Chemother       Date:  2016-09

3.  Antimicrobial misuse in pediatric urinary tract infections: recurrences and renal scarring.

Authors:  Jayaweera Arachchige Asela Sampath Jayaweera; Mohommed Reyes
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-06-25       Impact factor: 3.944

4.  Trends in Resistance to Extended-Spectrum Cephalosporins and Carbapenems among Escherichia coli and Klebsiella spp. Isolates in a District in Western India during 2004-2014.

Authors:  Ingvild Odsbu; Smita Khedkar; Frida Lind; Uday Khedkar; Sandeep S Nerkar; Nicola Orsini; Ashok J Tamhankar; Cecilia Stålsby Lundborg
Journal:  Int J Environ Res Public Health       Date:  2018-01-19       Impact factor: 3.390

5.  Detection of extended-spectrum beta-lactamase (ESBL) production by disc diffusion method among Pseudomonas species from various clinical samples.

Authors:  Ashish Kothari; Shailesh Kumar; Balram Ji Omar; Kamini Kiran
Journal:  J Family Med Prim Care       Date:  2020-02-28

6.  Prevalence of ESBL and AmpC genes in E. coli isolates from urinary tract infections in the north of Iran.

Authors:  M Sadeghi; H Sedigh Ebrahim-Saraie; A Mojtahedi
Journal:  New Microbes New Infect       Date:  2021-11-20

7.  Antimicrobial resistance in patients with suspected urinary tract infections in primary care in Assam, India.

Authors:  Deepjyoti Paul; Nimmy Anto; Mohit Bhardwaj; Alison Prendiville; Ravikrishnan Elangovan; Till T Bachmann; Debadatta Dhar Chanda; Amitabha Bhattacharjee
Journal:  JAC Antimicrob Resist       Date:  2021-12-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.